Mutation of Amino Acids 39–44 of Human CD14 Abrogates Binding of Lipopolysaccharide and Escherichia coli
Open Access
- 1 January 1997
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 243 (1-2), 100-109
- https://doi.org/10.1111/j.1432-1033.1997.00100.x
Abstract
As a key receptor for lipopolysaccharide (LPS) on the surface of monocytes and macrophages, the CD14 molecule is primarily involved in non-specific host defense mechanisms against gram-negative bacteria. To delineate the structural basis of LPS binding, 23 mutants in the N-terminal 252 amino acids of human CD14 were generated and stably transfected into CHO cells. In each mutant, a block of five amino acids was substituted by alanine. Reactivity of the mutants with anti-CD14 mAbs, and their ability to interact with LPS and Escherichia coli were tested. 4 of 21 expressed CD14 mutants, ([Ala9–Ala13]CD14, [Ala39–Ala41, Ala43, Ala44]CD14, [Ala51–Ala55]CD14 and [Ala57, Ala59, Ala61–Ala63]CD14), are not recognized by anti-CD14 mAbs that interfere with the binding of LPS to human monocytes. However, only [Ala39–Ala41, Ala43, Ala44lCD14 is unable to react with fluorescein-isothiocyanate-labeled LPS or with FITC-labeled E. coli (055:B5). In addition, [Ala39–Ala4t. Ala43, Ala44]CD14 does not mediate LPS (E. coli 055:B5; 10 ng/ml)-induced translocation of nuclear factor κB in CHO-cell transfectants. The results indicate that the region between amino acids 39 and 44 forms an essential part of the LPS-binding site of human CD14.Keywords
This publication has 28 references indexed in Scilit:
- The Myeloid Differentiation Antigen CD14 is N‐ and O‐GlycosylatedEuropean Journal of Biochemistry, 1996
- Both membrane‐bound and soluble forms of CD14 bind to Gram‐negative bacteriaEuropean Journal of Immunology, 1995
- Enzymatically Deacylated Lipopolysaccharide (LPS) Can Antagonize LPS at Multiple Sites in the LPS Recognition PathwayJournal of Biological Chemistry, 1995
- Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectantsEuropean Journal of Immunology, 1995
- Soluble CD14 Truncated at Amino Acid 152 Binds Lipopolysaccharide (LPS) and Enables Cellular Response to LPSPublished by Elsevier ,1995
- The two soluble forms of the lipopolysaccharide receptor, CD14: Characterization and release by normal human monocytesEuropean Journal of Immunology, 1994
- Endotoxin-neutralizing capacity of soluble CD14Research in Immunology, 1992
- Soluble CD14 participates in the response of cells to lipopolysaccharide.The Journal of Experimental Medicine, 1992
- Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.The Journal of Experimental Medicine, 1992
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990